Eusol Biotech Co.,Ltd. (TPEX:6652)
Taiwan
· Delayed Price · Currency is TWD 6.56
+0.21 (3.31%)
Mar 10, 2026, 1:46 PM CST
Eusol Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 193.18 | 248.65 | 213.69 | 144.66 | 248.08 | 72.83 | Upgrade
|
| Short-Term Investments | 132.91 | 95.51 | 165.6 | 250.6 | 30 | - | Upgrade
|
| Cash & Short-Term Investments | 326.09 | 344.16 | 379.29 | 395.26 | 278.08 | 72.83 | Upgrade
|
| Cash Growth | -10.48% | -9.26% | -4.04% | 42.14% | 281.83% | -52.67% | Upgrade
|
| Other Receivables | 25.35 | 28.99 | 24.56 | 18.18 | 18.42 | 19.1 | Upgrade
|
| Receivables | 25.44 | 28.99 | 24.56 | 18.18 | 18.42 | 19.1 | Upgrade
|
| Prepaid Expenses | 0.45 | 1.26 | 0.22 | 6.02 | 8.49 | 9.75 | Upgrade
|
| Other Current Assets | - | - | - | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Current Assets | 352.99 | 374.41 | 404.07 | 419.46 | 305 | 101.69 | Upgrade
|
| Property, Plant & Equipment | 1.5 | 2.99 | 5.74 | 10.71 | 78.01 | 91.26 | Upgrade
|
| Long-Term Investments | - | - | - | 10.1 | 9.91 | 11.05 | Upgrade
|
| Goodwill | - | - | - | 0.08 | 0.08 | 0.08 | Upgrade
|
| Other Intangible Assets | 0.03 | 0.08 | 0.05 | 0.06 | 60.88 | 75.63 | Upgrade
|
| Other Long-Term Assets | 1.07 | 0.44 | 0.4 | 0.4 | 1.03 | 1.4 | Upgrade
|
| Total Assets | 355.58 | 377.91 | 410.26 | 440.81 | 454.91 | 281.11 | Upgrade
|
| Accounts Payable | - | 0.32 | 0.39 | - | 0.51 | - | Upgrade
|
| Accrued Expenses | 6.82 | 3.4 | 4.18 | 6.05 | 13.93 | 9.75 | Upgrade
|
| Current Portion of Leases | 0.4 | 1.61 | 2.36 | 2.3 | 3.72 | 3.95 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 6.02 | - | 0.24 | Upgrade
|
| Other Current Liabilities | 0.88 | 2.16 | 0.74 | 0.65 | 1.96 | 2.56 | Upgrade
|
| Total Current Liabilities | 8.1 | 7.48 | 7.67 | 15.03 | 20.13 | 16.49 | Upgrade
|
| Long-Term Leases | - | - | 1.61 | 3.97 | 0.75 | 3.86 | Upgrade
|
| Total Liabilities | 8.1 | 7.48 | 9.28 | 18.99 | 20.88 | 20.36 | Upgrade
|
| Common Stock | 1,370 | 1,370 | 1,370 | 1,370 | 1,370 | 1,250 | Upgrade
|
| Additional Paid-In Capital | 551.51 | 551.51 | 551.51 | 551.51 | 551.51 | 371.51 | Upgrade
|
| Retained Earnings | -1,574 | -1,551 | -1,521 | -1,493 | -1,474 | -1,351 | Upgrade
|
| Comprehensive Income & Other | - | - | - | -7.11 | -13.21 | -9.8 | Upgrade
|
| Shareholders' Equity | 347.48 | 370.43 | 400.98 | 421.82 | 434.03 | 260.75 | Upgrade
|
| Total Liabilities & Equity | 355.58 | 377.91 | 410.26 | 440.81 | 454.91 | 281.11 | Upgrade
|
| Total Debt | 0.4 | 1.61 | 3.97 | 6.27 | 4.47 | 7.81 | Upgrade
|
| Net Cash (Debt) | 325.68 | 342.55 | 375.33 | 388.99 | 273.61 | 65.02 | Upgrade
|
| Net Cash Growth | -9.90% | -8.73% | -3.51% | 42.17% | 320.82% | -54.07% | Upgrade
|
| Net Cash Per Share | 2.38 | 2.50 | 2.74 | 2.84 | 2.04 | 0.52 | Upgrade
|
| Filing Date Shares Outstanding | 137 | 137 | 137 | 137 | 137 | 125 | Upgrade
|
| Total Common Shares Outstanding | 137 | 137 | 137 | 137 | 137 | 125 | Upgrade
|
| Working Capital | 344.88 | 366.93 | 396.4 | 404.43 | 284.88 | 85.19 | Upgrade
|
| Book Value Per Share | 2.54 | 2.70 | 2.93 | 3.08 | 3.17 | 2.09 | Upgrade
|
| Tangible Book Value | 347.45 | 370.36 | 400.94 | 421.67 | 373.08 | 185.04 | Upgrade
|
| Tangible Book Value Per Share | 2.54 | 2.70 | 2.93 | 3.08 | 2.72 | 1.48 | Upgrade
|
| Land | - | - | - | - | 12.1 | 12.1 | Upgrade
|
| Buildings | - | - | - | - | 55.74 | 55.74 | Upgrade
|
| Machinery | 13.14 | 15.36 | 16.62 | 20.15 | 92.35 | 92.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.